We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ENTG:NASDAQEntegris, Inc. Analysis

Data as of 2026-03-31 - not real-time

$116.43

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Entegris is trading at $116.43, just above its 20‑day SMA ($116.14) but still below the 50‑day SMA ($121.76), indicating a short‑term price edge that has not yet broken higher trends. The RSI sits at 48, well within the neutral zone, while the MACD line remains beneath its signal line, producing a bearish signal that aligns with the observed decreasing volume trend. A 30‑day volatility of nearly 60% and a computed beta of 2.47 highlight the stock’s heightened sensitivity to market swings, reinforcing a risk‑on profile despite a neutral overall trend. Fundamentally, the stock appears significantly overvalued with a trailing P/E of 75 versus an industry average of 32, though the forward P/E of 26.6 suggests earnings are expected to improve. The discounted cash‑flow model pins a fair value near $5, implying a 21% upside on a relative basis, but the stark contrast with the current price points to a valuation disconnect. Dividend yield is modest at 0.37% with a payout ratio under 30%, supporting dividend sustainability, yet the balance sheet bears a high debt‑to‑equity ratio of 96% and total debt of $3.8 B, raising leverage concerns. Recent headlines about a potential $4 trillion government consortium to fund semiconductor supply chains could provide a tailwind for demand, but analysts remain cautious, noting limited direct AI exposure and a 50% YTD rally that may have already priced in much of the upside.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume
  • Current price still above immediate support
  • High short‑term volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward P/E suggests earnings improvement
  • Potential demand boost from government semiconductor funding
  • Elevated leverage and overvaluation caution

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular growth in semiconductor materials and purity solutions
  • Sustainable dividend with low payout ratio
  • Long‑run valuation correction potential

Key Metrics & Analysis

Financial Health

Revenue Growth-3.00%
Profit Margin7.37%
P/E Ratio75.1
ROE6.16%
ROA3.62%
Debt/Equity96.42
P/B Ratio4.5
Op. Cash Flow$695.4M
Free Cash Flow$317.8M
Industry P/E32.4

Technical Analysis

TrendNeutral
RSI48.4
Support$107.25
Resistance$129.96
MA 20$116.14
MA 50$121.76
MA 200$95.42
MACDBearish
VolumeDecreasing
Fear & Greed Index74.36

Valuation

Fair Value$5.00
Target Price$141.40
Upside/Downside21.45%
GradeOvervalued
TypeBlend
Dividend Yield0.37%

Risk Assessment

Beta2.47
Volatility59.60%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.